ESMO Preceptorship on Gastric Cancer 2022: Singapore
- Start date
- 30 Nov 2022
- End date
- 01 Dec 2022
- Location
- Singapore, Republic of Singapore
Learning objectives
- To learn the fundamental of epidemiology, aetiology, pathogenesis, molecular events, and ethnic patterns as contributing factors to heterogeneity in gastric cancer (GC)
- To understand the importance of pathology and molecular factors
- To learn about best clinical practice in the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) and esophageal squamous cell cancers in the adjuvant and metastatic settings
- To learn about current best practice for endoscopic and surgical resection of localized gastric cancer
- To be able to compare the benefits of neo-adjuvant, adjuvant approaches and the value of radiotherapy in the management of localized gastro-esophageal cancers
- To learn about the management of patients after progression, in special situations and side effects of treatments
- To learn about the advances in the treatment and novel targets in gastric cancer
Accreditation
The programme of this event has been accredited with 8 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs:
- Florian Lordick, Germany
- Matthew C. H. Ng, Singapore
Supported by
